Thromboprophylaxis in gynecologic cancer surgery: Is extended prophylaxis with low molecular weight heparin justified?
European Journal of Obstetrics & Gynecology and Reproductive Biology(2018)
Abstract
Extended prophylaxis for 28 days with enoxaparin did not improve the rates of VTE following gynecologic oncological surgery in our series compared to the 7-day therapy, although neither was this extended duration associated with adverse events or mortality.
MoreTranslated text
Key words
Thromboprophylaxis,Gynecologic cancer surgery,Low molecular weight heparin,Venous thromboembolism,Thromboembolic disease
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined